01 Aug Diabetic? Tree Nuts May Help Control Your Blood Sugar
MedicalResearch.com Interview with:
Effie Viguiliouk
M.Sc. Candidate, Department of Nutritional Sciences
University of Toronto
Medical Research: What are the main findings of the study?
Effie Viguiliouk: This systematic review and meta-analysis of the totality of evidence from 12 randomized clinical trials in 450 participants with type 2 diabetes found that eating about 1/2 a cup of tree nuts per day (equivalent to about 60 g or 2 servings) significantly lowered the two key markers of blood sugar, HbA1c and fasting glucose, in comparison to calorically matched control diets without tree nuts.
Medical Research: Were any of the findings unexpected?
Effie Viguiliouk: We found that the greatest reductions were seen when tree nuts replaced refined carbohydrates (high-glycemic index carbohydrates) rather than saturated fats.
Medical Research: What should clinicians and patients take away from your report?
Effie Viguiliouk: Given that people in North America consume on average less than 1 serving of tree nuts a day, this is one way they can adapt their diets to take advantage of the metabolic benefits. One serving of tree nuts is about ¼ cup or 30 grams. Inclusion of about 1/2 a cup of tree nuts (which includes such things as almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, pine nuts, pistachios and walnuts, but not peanuts) as part of a healthy diet can help with lowering and stabilizing blood sugar levels in individuals with type 2 diabetes.
Medical Research: What recommendations do you have for future research as a result of this study?
Effie Viguiliouk: In order to address the sources of uncertainty in our analyses, there is a need for longer, higher quality trials that use tree nuts to lower the glycemic load of the diet by displacing high-glycemic index carbohydrates with a specific focus on glycemic endpoints as a primary outcome. The inclusion of such trials in future meta-analyses will help guide the development of nutrition recommendations and health claims, as well as the planning of future trials.
Citation:
Last Updated on June 4, 2015 by Marie Benz MD FAAD